
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte, et al.
Cancer Discovery (2017) Vol. 8, Iss. 2, pp. 196-215
Open Access | Times Cited: 466
Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte, et al.
Cancer Discovery (2017) Vol. 8, Iss. 2, pp. 196-215
Open Access | Times Cited: 466
Showing 1-25 of 466 citing articles:
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, et al.
Cell (2018) Vol. 175, Iss. 4, pp. 998-1013.e20
Open Access | Times Cited: 1622
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, et al.
Cell (2018) Vol. 175, Iss. 4, pp. 998-1013.e20
Open Access | Times Cited: 1622
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed, Lieping Chen
Cell (2018) Vol. 175, Iss. 2, pp. 313-326
Open Access | Times Cited: 1187
Miguel F. Sanmamed, Lieping Chen
Cell (2018) Vol. 175, Iss. 2, pp. 313-326
Open Access | Times Cited: 1187
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal, Xingnan Li, Junjie Zhu, et al.
Cell (2018) Vol. 175, Iss. 7, pp. 1972-1988.e16
Open Access | Times Cited: 1132
James T. Neal, Xingnan Li, Junjie Zhu, et al.
Cell (2018) Vol. 175, Iss. 7, pp. 1972-1988.e16
Open Access | Times Cited: 1132
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Noam Auslander, Gao Zhang, Joo Sang Lee, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1545-1549
Open Access | Times Cited: 618
Noam Auslander, Gao Zhang, Joo Sang Lee, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1545-1549
Open Access | Times Cited: 618
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng, Eric S. Wang, Russell W. Jenkins, et al.
Cancer Discovery (2017) Vol. 8, Iss. 2, pp. 216-233
Open Access | Times Cited: 607
Jiehui Deng, Eric S. Wang, Russell W. Jenkins, et al.
Cancer Discovery (2017) Vol. 8, Iss. 2, pp. 216-233
Open Access | Times Cited: 607
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim, Hyemin Mun, Chang Ohk Sung, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 587
Minsuh Kim, Hyemin Mun, Chang Ohk Sung, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 587
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 526
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 526
Organ-on-a-Chip: A New Paradigm for Drug Development
Chao Ma, Yansong Peng, Hongtong Li, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 2, pp. 119-133
Open Access | Times Cited: 395
Chao Ma, Yansong Peng, Hongtong Li, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 2, pp. 119-133
Open Access | Times Cited: 395
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, et al.
Cancer Discovery (2018) Vol. 9, Iss. 1, pp. 34-45
Open Access | Times Cited: 391
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, et al.
Cancer Discovery (2018) Vol. 9, Iss. 1, pp. 34-45
Open Access | Times Cited: 391
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J. Hill, Brennan Decker, Emma A. Roberts, et al.
Cancer Discovery (2018) Vol. 8, Iss. 11, pp. 1404-1421
Open Access | Times Cited: 373
Sarah J. Hill, Brennan Decker, Emma A. Roberts, et al.
Cancer Discovery (2018) Vol. 8, Iss. 11, pp. 1404-1421
Open Access | Times Cited: 373
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 358
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 358
Organoid and Spheroid Tumor Models: Techniques and Applications
Sreenivasulu Gunti, Austin T.K. Hoke, Kenny Vu, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 874-874
Open Access | Times Cited: 314
Sreenivasulu Gunti, Austin T.K. Hoke, Kenny Vu, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 874-874
Open Access | Times Cited: 314
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Brian Diskin, Salma Adam, Marcelo Ferreira Cassini, et al.
Nature Immunology (2020) Vol. 21, Iss. 4, pp. 442-454
Closed Access | Times Cited: 309
Brian Diskin, Salma Adam, Marcelo Ferreira Cassini, et al.
Nature Immunology (2020) Vol. 21, Iss. 4, pp. 442-454
Closed Access | Times Cited: 309
Organoid Models of Tumor Immunology
Kanako Yuki, Ning Cheng, Michitaka Nakano, et al.
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 652-664
Open Access | Times Cited: 287
Kanako Yuki, Ning Cheng, Michitaka Nakano, et al.
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 652-664
Open Access | Times Cited: 287
Treatment of Advanced Melanoma in 2020 and Beyond
Russell W. Jenkins, David E. Fisher
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 1, pp. 23-31
Open Access | Times Cited: 279
Russell W. Jenkins, David E. Fisher
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 1, pp. 23-31
Open Access | Times Cited: 279
Organoids in immunological research
Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Hans Clevers
Nature reviews. Immunology (2019) Vol. 20, Iss. 5, pp. 279-293
Open Access | Times Cited: 269
Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Hans Clevers
Nature reviews. Immunology (2019) Vol. 20, Iss. 5, pp. 279-293
Open Access | Times Cited: 269
Tumor organoid–T-cell coculture systems
Chiara Cattaneo, Krijn K. Dijkstra, Lorenzo F. Fanchi, et al.
Nature Protocols (2019) Vol. 15, Iss. 1, pp. 15-39
Open Access | Times Cited: 266
Chiara Cattaneo, Krijn K. Dijkstra, Lorenzo F. Fanchi, et al.
Nature Protocols (2019) Vol. 15, Iss. 1, pp. 15-39
Open Access | Times Cited: 266
Immunometabolic Interplay in the Tumor Microenvironment
Irem Kaymak, Kelsey S. Williams, Jason R. Cantor, et al.
Cancer Cell (2020) Vol. 39, Iss. 1, pp. 28-37
Open Access | Times Cited: 258
Irem Kaymak, Kelsey S. Williams, Jason R. Cantor, et al.
Cancer Cell (2020) Vol. 39, Iss. 1, pp. 28-37
Open Access | Times Cited: 258
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1143-1150
Open Access | Times Cited: 257
Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1143-1150
Open Access | Times Cited: 257
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1250-1261
Closed Access | Times Cited: 239
Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1250-1261
Closed Access | Times Cited: 239
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade
Amir Reza Aref, Marco Campisi, Elena Ivanova, et al.
Lab on a Chip (2018) Vol. 18, Iss. 20, pp. 3129-3143
Open Access | Times Cited: 215
Amir Reza Aref, Marco Campisi, Elena Ivanova, et al.
Lab on a Chip (2018) Vol. 18, Iss. 20, pp. 3129-3143
Open Access | Times Cited: 215
Tumor organoids: Opportunities and challenges to guide precision medicine
Vivien Veninga, Emile E. Voest
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1190-1201
Closed Access | Times Cited: 207
Vivien Veninga, Emile E. Voest
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1190-1201
Closed Access | Times Cited: 207
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang, Jill M. Marinis, Allison M. Beal, et al.
Cancer Cell (2018) Vol. 34, Iss. 5, pp. 757-774.e7
Open Access | Times Cited: 206
Wei Wang, Jill M. Marinis, Allison M. Beal, et al.
Cancer Cell (2018) Vol. 34, Iss. 5, pp. 757-774.e7
Open Access | Times Cited: 206
Targeting Notch in oncology: the path forward
Samarpan Majumder, Judy S. Crabtree, Todd E. Golde, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 125-144
Closed Access | Times Cited: 204
Samarpan Majumder, Judy S. Crabtree, Todd E. Golde, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 125-144
Closed Access | Times Cited: 204
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
Tristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 203
Tristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 203